Skip to main content

Table 3 The comparison of variables in the control group (splint) at the beginning and end of study

From: Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial

Variables Group Number Mean SD P value
VAS Before 20 6.24 1.13 < 0.001
After 20 3.52 2.02
MedSNAP PL Before 20 4.05 0.25 0.001
After 20 3.75 0.35
MedCMAP OL Before 20 4.06 0.59 0.002
After 20 4.07 0.55
SSS Before 20 2.76 0.40 < 0.001
After 20 1.90 0.42
FS Before 20 2.54 0.63 < 0.001
After 20 1.82 0.42